Woburn, MA, April 13, 2000
AlphaGene, Inc., an integrated genomics company
developing novel technologies for gene discovery to
accelerate drug development for major human
diseases, today announced the appointment of William
D. Hough to the position of Vice President of
Business Development and Strategic Planning.
Mr. Hough will assume the responsibility for
broadening operational and business development
functions of the company. Mr. Hough is a
pharmaceutical marketing executive with extensive US
and international experience in top pharmaceutical
companies. His expertise includes the developing,
managing, and revitalizing core businesses and
establishing overall business marketing services.
Prior to joining AlphaGene, Mr. Hough managed his
own consulting firm, Global Launch Consultants, for
two years. Previously, Mr. Hough spent 12 years with
Pharmacia & Upjohn in a variety of management
positions, including Director of Strategic Marketing
for Asia Pacific and Latin America, Vice President
of Marketing for Latin America, Vice President of
Marketing for the US, and General Manager of the
Philippines.
Mr. Hough worked with Pfizer, Lederle, and Johnson &
Johnson, in the US and overseas. He received his
B.A. in Political Science from Trinity College in
Hartford, Connecticut.
"AlphaGene is very fortunate to have a person
with such a strong record of accomplishments at this
juncture of the company's development" said
Donald J. McCarren, Ph.D., President and Chief
Executive Officer.
About AlphaGene, Inc.
AlphaGene, Inc. (http://www.alphagene.com)
is a privately held functional genomics company
offering products and services to biotech and
pharmaceutical companies engaged in drug discovery and
development. AlphaGene uses its large inventory of
full-length cDNAs and Bioinformatics expertise to
bridge the gap between genomics and functional
proteomics. The company focuses on differential gene
expression in degenerative neurological diseases
including Parkinson's and Alzheimer's
Diseases.
